top of page
32200c5c-7c4c-438f-a9df-3119a2398bf2.png
Autchmaber1.png
ai-cvd.png
AI-CVD Summary
Coronary Calcification
816_aicvd (8)_4_edited.jpg
‌ Aortic Calcification
ٍEpicardial Fat _edited.jpg
Epicardial Fat
816_aicvd (8)_5_edited.jpg
Cardiac Chambers
816_aicvd (8)_7_edited.jpg
Aorta & PA Size
816_aicvd (8)_10_edited.jpg
Lung LAI
816_aicvd (8)_9_edited.jpg
Lung HAI
816_aicvd (8)_11_edited.jpg
Liver Fat
816_aicvd (8)_12_edited.jpg
Muscle & Visceral Fat
816_aicvd (8)_13_edited.jpg
Bone Density
f055739f-1956-41a1-8156-cda95d1fea9f.png
AI-CVD Bundle
Muscle and Fat Analysis.png
Liver Attenuation.png
Cardiac Chambers Volumetry.png
ٍEpicardial Fat .png
Bone Mineral Density (BMD) .png
coronaryArteryCalcification.png
Lung Density Report- High Attenuation Index.png
Thoracic Aorta and Pulmonary Artery Sizing .png
Aortic Wall Aortic and Mitral Valve Report.png
Lung Density Report- Low Attenuation Index.png
AI-CVD--.png
Frame 1000008286.png
Frame 1000008286.png
Frame 1000008287.png

Automated Left Ventricular Volumetry using Artificial Intelligence in Coronary Calcium Scans (AI-CAC) Predicts Heart Failure Comparably to Cardiac MRI and Outperforms NT-proBNP:

Nov 27, 2024
2 min read

The Multi-Ethnic Study of Atherosclerosis (MESA)


Address for correspondence:

Morteza Naghavi, 2450 Holcombe, Houston, TX, 77021. 650-448-8089. mn@vp.org


AUTHORS (FIRST NAME, LAST NAME):

Morteza Naghavi, Anthony Reeves, Kyle Atlas, Dong Li, Chenyu Zhang, Thomas Atlas, Sion K. Roy, Matthew Budoff, Claudia Henschke, David Yankelevitz, Nathan D. Wong, and Daniel Levy.


a.     HeartLung.AI, Houston, TX

b.     Department of Computer Engineering, Cornell University, Ithaca, NY

c.     The Lundquist Institute, Torrance, CA

d.     Tustin Teleradiology, Tustin, CA

e.     Mount Sinai Hospital, New York, NY

f.      Heart Disease Prevention Program, Division of Cardiology, University of California, Irvine, CA

g.     National Institutes of Health, Bethesda, Maryland


Abstract:


Introduction:

Artificial intelligence-powered coronary artery calcium scan (AI-CAC) provides more actionable information than currently reported. In this study we compared left ventricular (LV) volume measured by AI-CAC versus cardiac magnetic resonance imaging (CMR) and NT-proBNP for predicting heart failure (HF). Additionally, we compared AI-CAC vs. NT-proBNP for detection of left ventricular hypertrophy (LVH) defined by CMR.


Methods:

We used 15-year outcomes data for incident heart failure (HF) from 3078 asymptomatic MESA participants (52.3% women, age 62.2±10.3 years) who underwent both CAC scans and CMR at the baseline examination. Data on CMR semi-manual LV volume, NT-proBNP, and Agatston CAC score were obtained from MESA. Discrimination was assessed using the time-dependent area under the curve (AUC) for incident HF.


Results:

Over 15 years of follow up, 133 cases of HF were diagnosed. The AUC for AI-CAC (0.789) and CMR (0.793) were not significantly different (p=0.67) but were significantly higher than NT-proBNP (0.719) and Agatston score (0.664) (p<.0001) for prediction of incident HF. AI-CAC and CMR significantly improved the continuous Net Reclassification Index of NT-proBNP (0.37) and Agatston score (0.45) for HF prediction (p<0.001 for all). The AUC for AI-CAC vs. NT-proBNP for LVH was 0.871 vs. 0.600 for males and 0.854 vs. 0.600 for females.


Conclusion:


In MESA, AI-CAC automated LV volumetry and CMR semi-automated LV volumetry equally predicted incident HF over 15 years and outperformed NT-proBNP. AI-CAC significantly outperformed NT-proBNP for detection of LVH. Both AI-CAC and CMR significantly improved on NT-proBNP and Agatston CAC score for predicting incident HF.

 

Keywords: coronary artery calcium, artificial intelligence, cardiac magnetic resonance imaging, left ventricular volume, heart failure.




Comments


Ready to Unlock the Value in Your CT Scans?

Join leading healthcare providers using AI-CVD to save lives and increase revenue, and lead the future of preventive cardiology.

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Youtube

2450 Holcombe Blvd
TMC Innovations
Houston, TX 77021

aicvd patent_edited_edited.jpg
ISO LOGO_edited.png
autoliver patent.png

©2026 HeartLung Corporation. All Rights Reserved. US Patent Nos US9119590*, US10695022, US11610686, US18167691, US20240115224, and Patents Pending. AI-CVD, AI-CAC, AutoBMD, AutoCAC, AutoChamber and other trademarks shown on this website are protected under intellectual property rights of HeartLung Corporation in the United States.

bottom of page